Literature DB >> 16132938

[Acute coronary syndrome in the prehospital phase].

J-H Schiff1, H R Arntz, B W Böttiger.   

Abstract

Cardiovascular diseases are the number one cause of death in Germany. In 2002 about 70,000 people died of acute myocardial infarction (AMI) and of these 37% died before arrival at hospital which underlines the relevance of adequate prehospital care. The generic term acute coronary syndrome (ACS) was introduced because a single pathomechanism accounts for the different forms and comprises unstable angina pectoris (iAP), non-ST-elevation myocardial infarction (NSTEMI), ST-elevation myocardial infarction (STEMI) and sudden cardiac death (SCD). Characteristic features are retrosternal pain, vegetative symptoms and radiation of pain into the adjoining regions. Further differentiation can only be achieved by the 12-lead ECG, as cardiac-specific enzymes do not play a role in prehospital decisions. Prehospital delays should be avoided, history and physical examination should be brief but focused, vital parameters should be assessed and monitored. Basic treatment for ACS should comprise inhalative oxygen, nitrates, morphine, aspirin and beta-blockers. If STEMI is diagnosed, patients with symptoms <12 h should undergo fibrinolytic therapy unless there is primary percutaneous coronary intervention (PCI) available within 90 min or if contraindicated. Heparin should be given to patients with STEMI depending on the choice of fibrinolytic agent, it otherwise results in a higher risk of bleeding, but in patients with iAP or NSTEMI it reduces mortality. All patients must be accompanied by the emergency physician during transportation and should be brought to a hospital with primary PCI, especially those with complicated ACS. Treatment of complications depends largely on the type, persistence and severity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132938     DOI: 10.1007/s00101-005-0897-z

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  144 in total

1.  Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis.

Authors:  L J Morrison; P R Verbeek; A C McDonald; B V Sawadsky; D J Cook
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).

Authors:  A J Tiefenbrunn; N C Chandra; W J French; J M Gore; W J Rogers
Journal:  J Am Coll Cardiol       Date:  1998-05       Impact factor: 24.094

3.  Fatality outside hospital from acute coronary events in three British health districts, 1994-5. United Kingdom Heart Attack Study Collaborative Group.

Authors:  R M Norris
Journal:  BMJ       Date:  1998-04-04

4.  Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-08-05       Impact factor: 91.245

5.  International diagnostic criteria for acute myocardial infarction and acute stroke.

Authors:  R F Gillum; S P Fortmann; R J Prineas; T E Kottke
Journal:  Am Heart J       Date:  1984-07       Impact factor: 4.749

6.  Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.

Authors:  J W Eikelboom; S S Anand; K Malmberg; J I Weitz; J S Ginsberg; S Yusuf
Journal:  Lancet       Date:  2000-06-03       Impact factor: 79.321

7.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial.

Authors:  W D Weaver; M Cerqueira; A P Hallstrom; P E Litwin; J S Martin; P J Kudenchuk; M Eisenberg
Journal:  JAMA       Date:  1993-09-08       Impact factor: 56.272

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

9.  Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis.

Authors:  M Dalby; A Bouzamondo; P Lechat; G Montalescot
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690

10.  Left ventricular remodelling, neurohormonal activation and early treatment with enalapril (CONSENSUS II) following myocardial infarction.

Authors:  A Sigurdsson; K Swedberg
Journal:  Eur Heart J       Date:  1994-05       Impact factor: 29.983

View more
  1 in total

1.  [Permissive anemia in patients with acute coronary syndrome].

Authors:  O Habler
Journal:  Anaesthesist       Date:  2005-10       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.